Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation

Cristina Gallo, Katiuscia Dallaglio, Barbara Bassani, Teresa Rossi, Armando Rossello, Douglas M Noonan, Gabriele D'Uva, Antonino Bruno, Adriana Albini

Research output: Contribution to journalArticle

Abstract

Angiogenesis, a process characterized by the formation of new blood vessels from pre-existing ones, is a crucial step in tumor growth and dissemination. Recently, increased attention has been addressed to the ability of flavonoids to prevent cancer by suppressing angiogenesis, strategy that we named "angioprevention". Several natural compounds exert their anti-tumor properties by activating 5' adenosine monophosphate-activated protein kinase (AMPK), a key regulator of metabolism in cancer cells. Drugs with angiopreventive activities, in particular metformin, regulate AMPK in endothelial cells. Here we investigated the involvement of AMPK in the anti-angiogenic effects of xanthohumol (XN), the major prenylated flavonoid of the hop plant, and mechanisms of action. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK phosphorylation and activity. Functional studies using biochemical approaches confirmed that AMPK mediates XN anti-angiogenic activity. AMPK activation by XN was mediated by CAMMKβ, but not LKB1. Analysis of the downstream mechanisms showed that XN-induced AMPK activation reduced nitric oxide (NO) levels in endothelial cells by decreasing eNOS phosphorylation. Finally, AKT pathway was inactivated by XN as part of its anti-angiogenic activity, but independently from AMPK, suggesting that these two signaling pathways proceed autonomously. Our study dissects the molecular mechanism by which XN exerts its potent anti-angiogenic activity, pointing out AMPK as a crucial signal transducer.

Original languageEnglish
Pages (from-to)59917-59931
Number of pages15
JournalOncotarget
Volume7
Issue number37
DOIs
Publication statusPublished - 2016

Fingerprint

Humulus
Adenosine Monophosphate
Flavonoids
Protein Kinases
Endothelial Cells
Neoplasms
Phosphorylation
xanthohumol
Metformin
Transducers
Blood Vessels
Nitric Oxide

Keywords

  • AMPK
  • Angiogenesis
  • Endothelial cells
  • Polyphenols
  • Xanthohumol

ASJC Scopus subject areas

  • Oncology

Cite this

Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation. / Gallo, Cristina; Dallaglio, Katiuscia; Bassani, Barbara; Rossi, Teresa; Rossello, Armando; Noonan, Douglas M; D'Uva, Gabriele; Bruno, Antonino; Albini, Adriana.

In: Oncotarget, Vol. 7, No. 37, 2016, p. 59917-59931.

Research output: Contribution to journalArticle

Gallo, Cristina ; Dallaglio, Katiuscia ; Bassani, Barbara ; Rossi, Teresa ; Rossello, Armando ; Noonan, Douglas M ; D'Uva, Gabriele ; Bruno, Antonino ; Albini, Adriana. / Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation. In: Oncotarget. 2016 ; Vol. 7, No. 37. pp. 59917-59931.
@article{6bb9ff72da9440b58c93c325e0020ad1,
title = "Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation",
abstract = "Angiogenesis, a process characterized by the formation of new blood vessels from pre-existing ones, is a crucial step in tumor growth and dissemination. Recently, increased attention has been addressed to the ability of flavonoids to prevent cancer by suppressing angiogenesis, strategy that we named {"}angioprevention{"}. Several natural compounds exert their anti-tumor properties by activating 5' adenosine monophosphate-activated protein kinase (AMPK), a key regulator of metabolism in cancer cells. Drugs with angiopreventive activities, in particular metformin, regulate AMPK in endothelial cells. Here we investigated the involvement of AMPK in the anti-angiogenic effects of xanthohumol (XN), the major prenylated flavonoid of the hop plant, and mechanisms of action. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK phosphorylation and activity. Functional studies using biochemical approaches confirmed that AMPK mediates XN anti-angiogenic activity. AMPK activation by XN was mediated by CAMMKβ, but not LKB1. Analysis of the downstream mechanisms showed that XN-induced AMPK activation reduced nitric oxide (NO) levels in endothelial cells by decreasing eNOS phosphorylation. Finally, AKT pathway was inactivated by XN as part of its anti-angiogenic activity, but independently from AMPK, suggesting that these two signaling pathways proceed autonomously. Our study dissects the molecular mechanism by which XN exerts its potent anti-angiogenic activity, pointing out AMPK as a crucial signal transducer.",
keywords = "AMPK, Angiogenesis, Endothelial cells, Polyphenols, Xanthohumol",
author = "Cristina Gallo and Katiuscia Dallaglio and Barbara Bassani and Teresa Rossi and Armando Rossello and Noonan, {Douglas M} and Gabriele D'Uva and Antonino Bruno and Adriana Albini",
year = "2016",
doi = "10.18632/oncotarget.10990",
language = "English",
volume = "7",
pages = "59917--59931",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "37",

}

TY - JOUR

T1 - Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation

AU - Gallo, Cristina

AU - Dallaglio, Katiuscia

AU - Bassani, Barbara

AU - Rossi, Teresa

AU - Rossello, Armando

AU - Noonan, Douglas M

AU - D'Uva, Gabriele

AU - Bruno, Antonino

AU - Albini, Adriana

PY - 2016

Y1 - 2016

N2 - Angiogenesis, a process characterized by the formation of new blood vessels from pre-existing ones, is a crucial step in tumor growth and dissemination. Recently, increased attention has been addressed to the ability of flavonoids to prevent cancer by suppressing angiogenesis, strategy that we named "angioprevention". Several natural compounds exert their anti-tumor properties by activating 5' adenosine monophosphate-activated protein kinase (AMPK), a key regulator of metabolism in cancer cells. Drugs with angiopreventive activities, in particular metformin, regulate AMPK in endothelial cells. Here we investigated the involvement of AMPK in the anti-angiogenic effects of xanthohumol (XN), the major prenylated flavonoid of the hop plant, and mechanisms of action. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK phosphorylation and activity. Functional studies using biochemical approaches confirmed that AMPK mediates XN anti-angiogenic activity. AMPK activation by XN was mediated by CAMMKβ, but not LKB1. Analysis of the downstream mechanisms showed that XN-induced AMPK activation reduced nitric oxide (NO) levels in endothelial cells by decreasing eNOS phosphorylation. Finally, AKT pathway was inactivated by XN as part of its anti-angiogenic activity, but independently from AMPK, suggesting that these two signaling pathways proceed autonomously. Our study dissects the molecular mechanism by which XN exerts its potent anti-angiogenic activity, pointing out AMPK as a crucial signal transducer.

AB - Angiogenesis, a process characterized by the formation of new blood vessels from pre-existing ones, is a crucial step in tumor growth and dissemination. Recently, increased attention has been addressed to the ability of flavonoids to prevent cancer by suppressing angiogenesis, strategy that we named "angioprevention". Several natural compounds exert their anti-tumor properties by activating 5' adenosine monophosphate-activated protein kinase (AMPK), a key regulator of metabolism in cancer cells. Drugs with angiopreventive activities, in particular metformin, regulate AMPK in endothelial cells. Here we investigated the involvement of AMPK in the anti-angiogenic effects of xanthohumol (XN), the major prenylated flavonoid of the hop plant, and mechanisms of action. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK phosphorylation and activity. Functional studies using biochemical approaches confirmed that AMPK mediates XN anti-angiogenic activity. AMPK activation by XN was mediated by CAMMKβ, but not LKB1. Analysis of the downstream mechanisms showed that XN-induced AMPK activation reduced nitric oxide (NO) levels in endothelial cells by decreasing eNOS phosphorylation. Finally, AKT pathway was inactivated by XN as part of its anti-angiogenic activity, but independently from AMPK, suggesting that these two signaling pathways proceed autonomously. Our study dissects the molecular mechanism by which XN exerts its potent anti-angiogenic activity, pointing out AMPK as a crucial signal transducer.

KW - AMPK

KW - Angiogenesis

KW - Endothelial cells

KW - Polyphenols

KW - Xanthohumol

UR - http://www.scopus.com/inward/record.url?scp=84991320293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991320293&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10990

DO - 10.18632/oncotarget.10990

M3 - Article

VL - 7

SP - 59917

EP - 59931

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 37

ER -